appengine.ai

Artificial Intelligence | Machine Learning | Machine Perception Aetion | Delivers Real-world Evidence


Health Care, Life Science tool & services , Pharmaceutical, Software Boston, MA, United States

Aetion

Artificial Intelligence | Machine Learning | Machine Perception


Aetion | Delivers Real-world Evidence

Aetion

Health Care, Life Science tool & services , Pharmaceutical, Software


Boston, MA, United States

Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era. Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Flare Capital Partners, Lakestar, and Town Hall Ventures. Learn more at aetion.com, follow us at @aetioninc, and subscribe to our monthly newsletter, The Evidence Digest, at https://www.aetion.com/evidence-digest.

 

B2B

101 to 250

Series B

$96.3 M

Scaling Up

2015

 
 

Pharmaceuticals and Medical Products
Life Sciences Tools & Services
Healthcare

N/A

Revenue Growth

 
 

Analytics
IT and Security
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception
   Knowledge Representation and Reasoning


N/A


Image

Image

Video

Video

Audio

Audio

Text

Text

Semi-Structured

Semi-Structured

 

   Software


N/A


Deep Learning

Deep Learning

Search Algorithm

Search Algorithm

Decision Trees

Decision Trees

 
 

May 2020

  • FDA Partners with Aetion to Gather Real-World Data on the Coronavirus

Apr 2020

  • Aetion, HealthVerity Launch New Tools for Assessing COVID-19 Treatments

May 2019

  • Aetion Presentation Awarded ?Best Podium? at ISPOR 2019
 
 

View All

Engagement Manager

New York, New York

Senior Scientist (Epidemiology)

New York, New York

Scientist (Epidemiology)

New York, New York

Science Prospects

New York, New York

Director, Science

New York, New York

 
 

5

1

$110 M

Company was founded 2015 and it took almost 6 years (May 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

05/11/2021

Series C

$110 M

B Capital, Foresite Capital, New Enterprise Associates, Flare Capital Partners, Warburg Pincus

Date : 05/11/2021

Round: Series C

$ Raised: $110 M

Investors: B Capital, Foresite Capital, New Enterprise Associates, Flare Capital Partners, Warburg Pincus

 
 
Carolyn Magill


Carolyn Magill
CEO

John Turek


John Turek
CTO

Jeremy Rassen


Jeremy Rassen
Co-Founder, President and Chief Science Officer

Allon Rauer


Allon Rauer
Co-Founder & CTO